[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"heel-spur-syndrome\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:heel-spur-syndrome":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":5},"100634942","optimal-radiotherapy---heel-spur-syndrome---randomized-clinical-trial-100634942",false,"NCT07546240","Optimal Radiotherapy - Heel Spur Syndrome - Randomized Clinical Trial","Impact of Total Dose and Fractionation on Clinical Outcomes of Low-Dose Radiotherapy for Heel Spur Syndrome: Optimal Radiotherapy - Heel Spur Syndrome (ORHEELS) Randomized Clinical Trial","ORHEELS","Inclusion Criteria:\n\n* Patients aged 40 years or older.\n* Clinically confirmed painful Heel Spur Syndrome (plantar fasciitis) persisting for at least 3 months\n* No effect from previous orthopaedic, physical, or analgesic treatments.\n* General performance status ZUBROD 0-3.\n* Exclusion of other local conditions.\n* Patient readiness for follow-up contact.\n\nExclusion Criteria:\n\n* Prior radiotherapy for heel spur.\n* Local use of corticosteroids within 4 weeks before planned radiotherapy.\n* Previous trauma, surgery to the foot on the same side.\n* Systemic diseases (eg collagen vascular disease).\n* Pregnancy or breastfeeding.\n* Lack of written informed consent","ALL","40 Years",{"count":20,"type":21},366,"ESTIMATED","INTERVENTIONAL",[24],"NA","Heel Spur Syndrome (HSS), is a pathology characterized by chronic inflammation and degenerative changes that affect approximately 10% of adults. Although many patients respond to conservative care, about 30% experience persistent pain. Low-dose radiation therapy (LDRT) is a well-established European method with proven anti-inflammatory and immunomodulatory effects. The ORHEELS trial aims to assess whether a Polish standard dose of 6 Gy in 6 daily fractions (fx)(5 times\u002Fweek) is not inferior to the treatment with total dose of 3 Gy \u002F fx 0,5 Gy \u002Ffractionated twice weekly. The study is designed to assess the impact of intensity of treatment (daily (5 times \u002F week) versus twice weekly fractionation) on clinical outcomes.",[27],"Heel Spur Syndrome",[29,30,31,32],"Heel spur","Plantar fasciitis","Low-dose radiotherapy","Anti-inflammatory radiotherapy","RECRUITING","2026-04-16",{"date":36,"type":37},"2026-04-22","ACTUAL",{"date":39,"type":37},"2026-03-23",{"date":41,"type":21},"2030-03-22",{"name":43,"class":44},"Maria Sklodowska-Curie National Research Institute of Oncology","OTHER"]